Variant report

Variant	rs17356287
Chromosome Location	chr4:175133183-175133184
allele	C/T
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr4:175132325..175133854-chr4:175137410..175139370,2	K562	blood:
2	chr4:175132325..175134757-chr4:175137089..175139873,3	K562	blood:

Extended variants
information (count: 6 )
Associated
traits (count: 0)

rSNPs within LD-proxies of this variant (count:1)

rs_ID	r²[population]
rs17358230	1.00[AFR][1000 genomes];1.00[ASN][1000 genomes]

Variant overlapped rSNPs/rCNVs (count:5 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	nsv830155	chr4:174943809-175136483	Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS Bivalent Enhancer ZNF genes & repeats Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA	13 gene(s)	inside rSNPs	diseases
2	nsv1016910	chr4:174952788-175349057	Bivalent Enhancer Flanking Active TSS Active TSS Enhancers Weak transcription ZNF genes & repeats Flanking Bivalent TSS/Enh Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
3	nsv537363	chr4:174952788-175349057	Active TSS Bivalent Enhancer Weak transcription Enhancers Strong transcription ZNF genes & repeats Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	22 gene(s)	inside rSNPs	diseases
4	nsv881449	chr4:174984230-175225452	Bivalent/Poised TSS Weak transcription Flanking Bivalent TSS/Enh Strong transcription Active TSS Bivalent Enhancer Flanking Active TSS Enhancers ZNF genes & repeats Genic enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region lncRNA miRNA target site	19 gene(s)	inside rSNPs	diseases
5	nsv596234	chr4:175053051-175361437	Weak transcription Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent/Poised TSS Strong transcription ZNF genes & repeats Transcr. at gene 5' and 3' Genic enhancers	TF binding region CpG island Chromatin interactive region lncRNA miRNA miRNA target site	17 gene(s)	inside rSNPs	diseases

No data

Chromatin state (count:55 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:175132400-175133200	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr4:175132400-175133200	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
3	chr4:175132400-175133800	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
4	chr4:175132400-175133800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 1	blood
5	chr4:175132400-175134800	Active TSS	Placenta	Placenta
6	chr4:175132600-175133200	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
7	chr4:175132600-175133200	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
8	chr4:175132600-175133200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
9	chr4:175132600-175133200	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
10	chr4:175132600-175133200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin03	Skin
11	chr4:175132600-175133200	Bivalent Enhancer	Liver	Liver
12	chr4:175132600-175133200	Bivalent Enhancer	Esophagus	oesophagus
13	chr4:175132600-175133200	Bivalent Enhancer	Placenta Amnion	Placenta Amnion
14	chr4:175132600-175133200	Bivalent Enhancer	Sigmoid Colon	Sigmoid Colon
15	chr4:175132600-175133200	Bivalent Enhancer	Monocytes-CD14+_RO01746	blood
16	chr4:175132600-175133400	Bivalent Enhancer	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
17	chr4:175132600-175133400	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
18	chr4:175132600-175133400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
19	chr4:175132600-175133600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
20	chr4:175132600-175133600	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
21	chr4:175132600-175133600	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
22	chr4:175132600-175133800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
23	chr4:175132600-175133800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
24	chr4:175132600-175134000	Bivalent Enhancer	Fetal Muscle Leg	muscle
25	chr4:175132600-175134200	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
26	chr4:175132800-175133200	Flanking Bivalent TSS/Enh	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr4:175132800-175133200	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
28	chr4:175132800-175133200	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
29	chr4:175132800-175133200	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
30	chr4:175132800-175133200	Bivalent Enhancer	Primary T cells from cord blood	blood
31	chr4:175132800-175133200	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
32	chr4:175132800-175133200	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr4:175132800-175133200	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
34	chr4:175132800-175133200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
35	chr4:175132800-175133200	Bivalent Enhancer	Small Intestine	intestine
36	chr4:175132800-175133200	Enhancers	Spleen	Spleen
37	chr4:175132800-175133400	Bivalent Enhancer	Fetal Heart	heart
38	chr4:175132800-175133600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
39	chr4:175133000-175133200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
40	chr4:175133000-175133200	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
41	chr4:175133000-175133200	Bivalent/Poised TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
42	chr4:175133000-175133200	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
43	chr4:175133000-175133200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr4:175133000-175133200	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr4:175133000-175133200	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr4:175133000-175133200	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
47	chr4:175133000-175133200	Bivalent Enhancer	Brain Germinal Matrix	brain
48	chr4:175133000-175133200	Bivalent Enhancer	Fetal Stomach	stomach
49	chr4:175133000-175133200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
50	chr4:175133000-175133200	Bivalent Enhancer	GM12878-XiMat	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links